ADINA CATALOGUE
Shop the
complete catalogue.
Search by product name or browse by category. Price, availability and the most important distinction stay visible throughout.
Showing 1–24 of 57 results
-
Early human evidence
Acetyl Tetrapeptide-3
£37.0010 mgBatch file pendingScalp/follicle matrix focus distinguishes it from SNAP-8’s expression-line mechanism and GHK-Cu’s copper biology.
UnavailableAsk about availability -
Preclinical
AHK-CU
£40.99Batch file pendingAHK-CU uses the alanine–histidine–lysine sequence and has a narrower hair-follicle research record than the more widely studied GHK-Cu…
Available · 50 in stockAdd to basket -
Early human evidence
AOD-9604
£32.495 mgBatch file pendingA GH-derived metabolic fragment—not an incretin, amylin analogue or GH secretagogue.
Available · 10 in stockAdd to basket -
Clinical research
ARA-290 (Cibinetide)
£72.0010 mgBatch file pendingSeparates tissue-protective EPO signalling from red-blood-cell production.
UnavailableAsk about availability -
Specification review
Bacteriostatic Water
Price range: £4.49 through £8.9910 mL | 3 mLBatch file pendingA laboratory supply with two volume variants, not a peptide or biologically active comparison material.
AvailableAdd to basket This product has multiple variants. The options may be chosen on the product page -
Preclinical
BPC-157
£32.99Batch file pendingBPC-157 is mainly discussed around stomach and local tissue-repair models. TB-500 is instead studied for actin, cell movement…
Available · 30 in stockAdd to basket -
Preclinical
BPC-157 + TB-500
Price range: £42.99 through £79.995 mg + 5 mg | 10 mg + 10 mgBatch file pendingThe combination places a gastric-peptide-derived experimental material beside an actin-regulatory thymosin pathway, rather than combining two versions of…
AvailableAdd to basket This product has multiple variants. The options may be chosen on the product page -
Experimental
Bronchogen
£46.0020 mgBatch file pendingAirway-tissue focus rather than VIP’s defined VPAC-receptor bronchodilatory biology.
UnavailableAsk about availability -
Clinical research
Cagrilintide
£64.005 mgBatch file pendingTargets amylin biology, making it mechanistically distinct from every incretin agonist in the category.
UnavailableAsk about availability -
Experimental
Cartalax
£46.0020 mgBatch file pendingCartilage-cell focus, rather than BPC-157’s broader repair signalling or GHK-Cu’s collagen/copper biology.
UnavailableAsk about availability -
Early human evidence
CJC-1295 DAC
Price range: £32.99 through £39.995 mgBatch file pendingIts albumin-binding extension creates sustained exposure, unlike CJC-1295 No DAC or sermorelin.
Available · 10 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Early human evidence
CJC-1295 No DAC
Price range: £25.99 through £32.995 mgBatch file pendingShort-duration GHRH signalling, in contrast with albumin-bound, long-acting CJC-1295 DAC.
UnavailableAsk about availability This product has multiple variants. The options may be chosen on the product page -
Early human evidence
CJC-1295 No DAC + Ipamorelin
Price range: £59.99 through £79.995 mg + 5 mg | 10 mg + 10 mgBatch file pendingIt combines two complementary upstream receptor pathways without the albumin-binding DAC group that makes CJC-1295 DAC long acting.
AvailableAdd to basket This product has multiple variants. The options may be chosen on the product page -
Experimental
Dihexa
£66.0010 mgBatch file pendingHGF/c-Met synaptogenesis hypothesis, unlike Semax’s neurotrophic ACTH-fragment lineage.
UnavailableAsk about availability -
Early human evidence
DSIP
£13.995 mgBatch file pendingSleep is its historical research label, but mechanistic certainty is much lower than for receptor-defined peptides.
UnavailableAsk about availability -
Experimental
Endoluten
£46.0020 mgBatch file pendingPineal/circadian branding with uncertain composition, distinct from sequence-defined Epithalon.
UnavailableAsk about availability -
Preclinical
Epithalon
£58.0010 mgBatch file pendingA proposed pineal-derived bioregulator with telomere-focused claims, not a mitochondrial-targeting peptide.
UnavailableAsk about availability -
Experimental
Follistatin 344
£76.001 mgBatch file pendingA ligand-binding inhibitor of the activin/myostatin system, not a GH or IGF secretagogue.
UnavailableAsk about availability -
Preclinical
FOXO4-DRI
£92.0010 mgBatch file pendingA targeted experimental senolytic mechanism, not a mitochondrial support or endocrine peptide.
UnavailableAsk about availability -
Phase 2 clinical research
GHK-Cu
£24.99Batch file pendingGHK-Cu is a copper complex. Pal-GHK has a fatty tail for topical formulas, while non-copper peptides use different…
Available · 50 in stockAdd to basket -
Early human evidence
GHRP-2
£44.005 mgBatch file pendingTypically characterised as a strong GH secretagogue with less appetite emphasis than GHRP-6.
UnavailableAsk about availability -
Early human evidence
GHRP-6 Acetate
Price range: £19.99 through £39.995 mgBatch file pendingIts prominent appetite/ghrelin research profile distinguishes it from the more selective ipamorelin.
Available · 10 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Early human evidence
Hexarelin
£51.005 mgBatch file pendingA potent older GHRP with less hormonal selectivity than ipamorelin.
UnavailableAsk about availability -
Preclinical
Humanin
£68.0010 mgBatch file pendingPrimarily cytoprotective/anti-apoptotic, whereas MOTS-c centres on metabolic stress signalling.
UnavailableAsk about availability